Arnab Seth

@bharattechnology.in

Assistant Professor (Dept. of Pharmaceutical Chemistry)
Bharat Technology

Arnab Seth


               Download Compact PDF  
https://researchid.co/seth1995

EDUCATION

M. Pharm (Pharm. Tech., Jadavpur University)

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmaceutical Science, Organic Chemistry, Drug Discovery, Toxicology
3

Scopus Publications

220

Scholar Citations

4

Scholar h-index

3

Scholar i10-index

Scopus Publications

  • Therapeutic Advancement of Stem Cell Therapy in Atopic Dermatitis
    Kishanta Kumar Pradhan, Rojalin Samanta, Reechik Bandyopadhyay, Arnab Seth, Chowdhury Mobaswar Hossain
    Stem Cell Therapy in Dermatological Disorders, 2025
    Atopic dermatitis (AD) is an unrelenting seditious dermal condition provoked by immunological, ecological, and hereditary conditions that can result in mutilation and sensitivity to the epidermis. Disparity among T H 2 (T helper 2) and T H 1 cells and the genetic modifications put into the pathogenesis of AD lead to persistent inflammation and disease development. Stem cell treatment has come forth due to its resurgence and immune-modulation characteristics. Different types of stem cells, vis . mesenchymal, induced pluripotent, and embryonic stem cells, provide promising therapeutic activity using immune inflection, control of cytokines, and tissue recovery. Notwithstanding heartening consequences in preclinical and early clinical studies that facilitate future translational research, numerous tribulations endure, including regulatory barriers, ethical predicaments, and immunological refusals. Stem cell treatments have been improved through modern strategies such as gene-edited stem cell and exosome-based therapy. This chapter put forward an inclusive study of stem cell treatment, research aspects, ethical inferences, and further prospects in AD.
  • QSAR modeling of algal low level toxicity values of different phenol and aniline derivatives using 2D descriptors
    Arnab Seth, Kunal Roy
    Aquatic Toxicology, 2020
  • QSAR modeling with ETA indices for cytotoxicity and enzymatic activity of diverse chemicals
    Arnab Seth, Probir Kumar Ojha, Kunal Roy
    Journal of Hazardous Materials, 2020

RECENT SCHOLAR PUBLICATIONS

  • Artificial Intelligence, Deep Learning, and Machine Learning to Target ROS-Mediated Inflammation Inhibition in Metabolic Disorders
    A Seth, S Bandyapadhyay, A Palui, M Chatterjee
    Reactive Oxygen Species in Metabolic Inflammation, 417-433 , 2026
    2026
  • Therapeutic Advancement of Stem Cell Therapy in Atopic Dermatitis
    KK Pradhan, R Samanta, R Bandyopadhyay, A Seth, CM Hossain
    Stem Cell Therapy in Dermatological Disorders, 109-139 , 2025
    2025
  • Compound isolation followed by anti-inflammatory bioactivity-based ADME study, network pharmacology, molecular docking and MD simulation reveals a novel O-methylated flavonol …
    A Banerjee, S Paul, A Seth, B Debnath, A Kumar, S Das
    Pharmacological Research-Natural Products 8, 100284 , 2025
    2025
    Citations: 2
  • Antiviral Bioactive Compounds: Their Activities and Underlying Mechanisms Against Human Viral Infections
    S Ghosh, K Jana, P Parua, A Seth, A Bishal, B Debnath, SK Rout, ...
    Recent advances in anti-infective drug discovery , 2025
    2025
    Citations: 3
  • Therapeutic potential of neutralizing monoclonal antibodies (nMAbs) against SARS-CoV-2 omicron variant
    P Parua, S Ghosh, K Jana, A Seth, B Debnath, SK Rout, MK Sarangi, ...
    Current Pharmaceutical Design , 2024
    2024
    Citations: 4
  • Chitosan Derivatives as Carriers for Drug Delivery and Biomedical Applications
    SJ Sreejan Manna, Arnab Seth, Prajna Gupta, Gouranga Nandi, Ria Dutta ...
    ACS Biomater. Sci. Eng. 9 (4), 1730-2014 , 2023
    2023
    Citations: 152
  • QSAR modeling of algal low level toxicity values of different phenol and aniline derivatives using 2D descriptors
    A Seth, K Roy
    Aquatic Toxicology 228, 105627 , 2020
    2020
    Citations: 42
  • QSAR modeling with ETA indices for cytotoxicity and enzymatic activity of diverse chemicals
    A Seth, PK Ojha, K Roy
    Journal of hazardous materials 394, 122498 , 2020
    2020
    Citations: 17

MOST CITED SCHOLAR PUBLICATIONS

  • Chitosan Derivatives as Carriers for Drug Delivery and Biomedical Applications
    SJ Sreejan Manna, Arnab Seth, Prajna Gupta, Gouranga Nandi, Ria Dutta ...
    ACS Biomater. Sci. Eng. 9 (4), 1730-2014 , 2023
    2023
    Citations: 152
  • QSAR modeling of algal low level toxicity values of different phenol and aniline derivatives using 2D descriptors
    A Seth, K Roy
    Aquatic Toxicology 228, 105627 , 2020
    2020
    Citations: 42
  • QSAR modeling with ETA indices for cytotoxicity and enzymatic activity of diverse chemicals
    A Seth, PK Ojha, K Roy
    Journal of hazardous materials 394, 122498 , 2020
    2020
    Citations: 17
  • Therapeutic potential of neutralizing monoclonal antibodies (nMAbs) against SARS-CoV-2 omicron variant
    P Parua, S Ghosh, K Jana, A Seth, B Debnath, SK Rout, MK Sarangi, ...
    Current Pharmaceutical Design , 2024
    2024
    Citations: 4
  • Antiviral Bioactive Compounds: Their Activities and Underlying Mechanisms Against Human Viral Infections
    S Ghosh, K Jana, P Parua, A Seth, A Bishal, B Debnath, SK Rout, ...
    Recent advances in anti-infective drug discovery , 2025
    2025
    Citations: 3
  • Compound isolation followed by anti-inflammatory bioactivity-based ADME study, network pharmacology, molecular docking and MD simulation reveals a novel O-methylated flavonol …
    A Banerjee, S Paul, A Seth, B Debnath, A Kumar, S Das
    Pharmacological Research-Natural Products 8, 100284 , 2025
    2025
    Citations: 2
  • Artificial Intelligence, Deep Learning, and Machine Learning to Target ROS-Mediated Inflammation Inhibition in Metabolic Disorders
    A Seth, S Bandyapadhyay, A Palui, M Chatterjee
    Reactive Oxygen Species in Metabolic Inflammation, 417-433 , 2026
    2026
  • Therapeutic Advancement of Stem Cell Therapy in Atopic Dermatitis
    KK Pradhan, R Samanta, R Bandyopadhyay, A Seth, CM Hossain
    Stem Cell Therapy in Dermatological Disorders, 109-139 , 2025
    2025